Primary rhabdomyosarcoma: An extremely rare and aggressive variant of male breast cancer

doi:10.12998/wjcc.v8.i19.4466

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6006)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

275

WORD

186

HTML

2813

Figures (1-4)

895

Tables (1-2)

424

Sum=4593

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

526

Download

887

Sum=1413

Oct 6, 2020 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 6, 2020; 8(19): 4466-4474
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4466

Table 1 Immunohistochemical markers used to confirm the rhabdomyosarcoma with neuroectodermal differentiation

Antibody	Clone	Dilution	Manufacturer	Retrieval	RMS comp	NED comp	Line of differentiation confirmed
VIM	V9	RTU	DAKO^/ Denmark	High pH	+	+	Mesenchymal origin
DESM	D33	RTU	DAKO	High pH	+	-	Myogenic origin
MYO	F5D	1:100	ImmunoLogic/Netherland	High pH	+	-	Rhabdomyosarcoma component
SA	Alpha Sr-1	1:100	DAKO	Citrate	+	-	Rhabdomyosarcoma component
NF	2F11	1:100	DAKO	Citrate	-	+	Neuroectodermal component
NSE	BBS/NC/V1-414	RTU	DAKO	High pH	-	+	Neuroectodermal component
CD99	12E7	RTU	DAKO	High pH	-	+	Neuroectodermal component

Comp: Component; DESM: Desmin; MYO: Myogenin; NED: Neuroectodermal; NF: Neurofilament; NSE: Neuron specific enolase; SA: Sarcomeric actin; RMS: Rhabdomyosarcoma; RTU: Ready to use; VIM: Vimentin.

Citation: Satală CB, Jung I, Bara TJ, Simu P, Simu I, Vlad M, Szodorai R, Gurzu S. Primary rhabdomyosarcoma: An extremely rare and aggressive variant of male breast cancer. World J Clin Cases 2020; 8(19): 4466-4474
URL: https://www.wjgnet.com/2307-8960/full/v8/i19/4466.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i19.4466